Immunogen reported $1.12B in Market Capitalization this November of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US USD 237.3B 33.36B
Agios Pharmaceuticals AGIO:US USD 1.55B 335M
Amgen AMGN:US USD 120.36B 9.61B
Astellas Pharma 4503:JP JPY 3.52T 363.5B
AstraZeneca AZN:LN USD 154.08B 13.26B
Bluebird Bio BLUE:US USD 488M 192M
Bristol Myers Squibb BMY:US USD 151.8B 12.14B
Eli Lilly And LLY:US USD 307.24B 831M
Emergent Biosolutions EBS:US USD 1.05B 502M
Exelixis EXEL:US USD 5.05B 1.63B
Halozyme Therapeutics HALO:US USD 5.45B 622M
Heron Therapeutics HRTX:US USD 501M 215M
Immunogen IMGN:US USD 1.06B 63M
Intrexon XON:US USD 441M 163M
Karyopharm Therapeutics KPTI:US USD 442M 82M
Macrogenics MGNX:US USD 213M 32M
Nektar Therapeutics NKTR:US USD 600M 108M
Novartis NVS:US USD 183.98B 19.54B
Pfizer PFE:US USD 245.6B 48.58B
Regeneron Pharmaceuticals REGN:US USD 75.09B 10.16B
Roche Holding ROG:VX CHF 268.62B 31.88B
Sanofi SNY:US EUR 97.37B 30.4B
Seattle Genetics SGEN:US USD 25.24B 7.33B